Healthcare Innovation November 7, 2025
Geert De Lombaerde

CFO Celeste Mellet said the insurer is “not seeing anything” suggesting medical and pharmacy cost growth will slow in the coming year

There won’t be too much of a good thing at Humana Inc. in 2026.

Speaking to analysts and investors on Nov. 5 after the Louisville-based insurer and healthcare services provider reported its third-quarter results, President and CEO Jim Rechtin said his team is prepared to tap the brakes on Medicare sales during the current annual enrollment period. Outlining Humana’s focus on customers’ lifetime value over simply pumping enrollment numbers, Rechtin said he’s also adamant that Humana’s operations not be stretched by the addition of new plan members.

“We will take as much growth as possible from improved retention....

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Insurance, Payer
H.R.1 Threatens The Stability Of Medicaid Managed Care
WISeR in 2026: Legal, Compliance, and AI Challenges That Could Reshape Prior Authorization for Skin Substitutes
How To Keep Competition Alive In Medicaid Managed Care Markets
Fortifying Medicaid Managed Care for Postpartum Enrollees: The Clearest Path to Improving Maternal Health
UnitedHealth Group's earnings reflect industry-wide pressure

Share Article